The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery

被引:10
|
作者
Carvalho, Luis A. R. [1 ]
Bernardes, Goncalo J. L. [1 ,2 ]
机构
[1] Univ Cambridge, Yusuf Hamied Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England
[2] Inst Med Mol Joao Lobo Antunes, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal
基金
欧盟地平线“2020”;
关键词
Drug Discovery; Fluorescent probes; Malaria; Mass spectrometry; Proteomics; ACTIVITY-BASED PROBES; SMALL-MOLECULE INHIBITORS; PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; FUNCTIONAL PROTEOMICS; SERINE HYDROLASES; ARTEMISININ; SITE; IDENTIFICATION; REVEALS;
D O I
10.1002/cmdc.202200174
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Activity-based protein profiling (ABPP) is an approach used at the interface of chemical biology and proteomics that uses small molecular probes to provide dynamic fingerprints of enzymatic activity in complex proteomes. Malaria is a disease caused by Plasmodium parasites with a significant death burden and for which new therapies are actively being sought. Here, we compile the main achievements from ABPP studies in malaria and highlight the probes used and the different downstream platforms for data analysis. ABPP has excelled at studying Plasmodium cysteine proteases and serine hydrolase families, the targeting of the proteasome and metabolic pathways, and in the deconvolution of targets and mechanisms of known antimalarials. Despite the major impact in the field, many antimalarials and enzymatic families in Plasmodium remain to be studied, which suggests ABPP will be an evergreen technique in the field.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Activity-Based Profiling for Drug Discovery
    Serwa, Remigiusz
    Tate, Edward W.
    CHEMISTRY & BIOLOGY, 2011, 18 (04): : 407 - 409
  • [2] Activity-based protein profiling for functional proteomics and drug discovery.
    Patricelli, MP
    Okerberg, ES
    Wu, JY
    Zhang, BH
    Samii, B
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U532 - U532
  • [3] Applications of Activity-Based Protein Profiling (ABPP) and Bioimaging in Drug Discovery
    Xu, Jiaqian
    Li, Xiaoqian
    Ding, Ke
    Li, Zhengqiu
    CHEMISTRY-AN ASIAN JOURNAL, 2020, 15 (01) : 34 - 41
  • [4] Ligand discovery by activity-based protein profiling
    Niphakis, Micah J.
    Cravatt, Benjamin F.
    CELL CHEMICAL BIOLOGY, 2024, 31 (09) : 1636 - 1651
  • [5] Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
    Niphakis, Micah J.
    Cravatt, Benjamin F.
    ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83, 2014, 83 : 341 - 377
  • [6] Activity-based protein profiling for biochemical pathway discovery in cancer
    Nomura, Daniel K.
    Dix, Melissa M.
    Cravatt, Benjamin F.
    NATURE REVIEWS CANCER, 2010, 10 (09) : 630 - 638
  • [7] Activity-based protein profiling for biochemical pathway discovery in cancer
    Daniel K. Nomura
    Melissa M. Dix
    Benjamin F. Cravatt
    Nature Reviews Cancer, 2010, 10 : 630 - 638
  • [8] Activity-Based Protein Profiling for Natural Product Target Discovery
    Krysiak, Joanna
    Breinbauer, Rolf
    ACTIVITY-BASED PROTEIN PROFILING, 2012, 324 : 43 - 84
  • [9] Chemoproteomics and activity-based profiling as research tools for drug discovery at Genentech
    Lill, Jennie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [10] Activity-based Protein Profiling
    Wang Chu
    Chen Nan
    ACTA CHIMICA SINICA, 2015, 73 (07) : 657 - 668